| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
23,910,000 |
| Market
Cap: |
2.68(B) |
| Last
Volume: |
270,299 |
Avg
Vol: |
187,424 |
| 52
Week Range: |
$81.08 - $194.07 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 789 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ICU Medical is an infusion therapy company. Co. has four product lines: Infusion Consumables, which include Clave™ needlefree products, SwabCap and SwabTip disinfecting caps, ClearGuard HD antimicrobial barrier caps for hemodialysis catheters and Tego™ hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs; Infusion Systems, which provide infusion pumps, dedicated IV sets, software and other services; IV Solutions, which provide a supply of IV solutions, irrigation and nutritionals; and Critical Care, which helps clinicians get real-time access to patients' hemodynamic and cardiac status with a portfolio of monitoring systems and sensors and catheters.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
28,542 |
1,746,822 |
1,815,401 |
1,818,359 |
| Total Sell Value |
$2,942,495 |
$185,216,328 |
$197,313,260 |
$197,870,049 |
| Total People Sold |
5 |
8 |
9 |
9 |
| Total Sell Transactions |
8 |
15 |
19 |
24 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lopez George A |
Director |
– • • |
2018-07-03 |
4 |
AS |
$289.48 |
$1,864,169 |
D/D |
(6,409) |
373,444 |
|
- |
|
| Lopez George A |
Director |
– • • |
2018-07-02 |
4 |
AS |
$290.78 |
$4,600,527 |
D/D |
(15,795) |
379,853 |
|
- |
|
| Brummett Burcar Alison |
Vice President and Genl Mgr. |
• – – |
2018-06-21 |
4 |
S |
$295.27 |
$4,508,967 |
D/D |
(15,195) |
0 |
|
- |
|
| Brummett Burcar Alison |
Vice President and Genl Mgr. |
• – – |
2018-06-21 |
4 |
OE |
$58.79 |
$1,289,487 |
D/D |
15,195 |
15,195 |
|
- |
|
| Brummett Burcar Alison |
Vice President and Genl Mgr. |
• – – |
2018-06-20 |
4 |
S |
$300.73 |
$6,382,702 |
D/D |
(21,169) |
0 |
|
- |
|
| Brummett Burcar Alison |
Vice President and Genl Mgr. |
• – – |
2018-06-20 |
4 |
OE |
$58.79 |
$1,244,526 |
D/D |
21,169 |
21,169 |
|
- |
|
| Brummett Burcar Alison |
Vice President and Genl Mgr. |
• – – |
2018-06-19 |
4 |
S |
$300.20 |
$10,486,202 |
D/D |
(34,747) |
0 |
|
- |
|
| Brummett Burcar Alison |
Vice President and Genl Mgr. |
• – – |
2018-06-19 |
4 |
OE |
$58.79 |
$2,042,776 |
D/D |
34,747 |
34,747 |
|
- |
|
| Brummett Burcar Alison |
Vice President and Genl Mgr. |
• – – |
2018-06-18 |
4 |
S |
$301.56 |
$6,453,374 |
D/D |
(21,311) |
0 |
|
- |
|
| Brummett Burcar Alison |
Vice President and Genl Mgr. |
• – – |
2018-06-18 |
4 |
OE |
$58.79 |
$1,005,779 |
D/D |
17,108 |
21,311 |
|
- |
|
| Swinney Robert S |
Director |
– • – |
2018-06-11 |
4 |
AS |
$290.95 |
$99,796 |
D/D |
(343) |
18,040 |
|
- |
|
| Swinney Robert S |
Director |
– • – |
2018-06-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
18,383 |
|
- |
|
| Lopez George A |
Director |
– • • |
2018-06-06 |
4 |
AS |
$290.91 |
$2,706,133 |
D/D |
(9,272) |
395,716 |
|
- |
|
| Lopez George A |
Director |
– • • |
2018-06-05 |
4 |
AS |
$291.43 |
$3,248,502 |
D/D |
(11,128) |
404,988 |
|
- |
|
| Lopez George A |
Director |
– • • |
2018-06-04 |
4 |
AS |
$292.33 |
$3,693,886 |
D/D |
(12,600) |
416,116 |
|
- |
|
| Lopez George A |
Director |
– • • |
2018-05-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
68 |
428,648 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2018-05-24 |
4 |
S |
$273.67 |
$482,480 |
D/D |
(1,763) |
0 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2018-05-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
50 |
48,143 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2018-05-15 |
4 |
S |
$269.85 |
$134,925 |
D/D |
(500) |
617 |
|
- |
|
| Saucedo Joseph R |
Director |
– • – |
2018-05-14 |
4 |
S |
$269.02 |
$421,285 |
D/D |
(1,566) |
0 |
|
- |
|
| Finney Elisha W |
Director |
– • – |
2018-05-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
475 |
1,580 |
|
- |
|
| Swinney Robert S |
Director |
– • – |
2018-05-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
475 |
15,383 |
|
- |
|
| Greenberg David C. |
Director |
– • – |
2018-05-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
475 |
2,010 |
|
- |
|
| Saucedo Joseph R |
Director |
– • – |
2018-05-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
475 |
1,566 |
|
- |
|
| Lopez George A |
Director |
– • • |
2018-05-09 |
4 |
AS |
$252.18 |
$3,856,587 |
D/D |
(15,084) |
428,716 |
|
- |
|
839 Records found
|
|
Page 17 of 34 |
|
|
3.83 (3.54%) 
